within Pharmacolibrary.Drugs.ATC.L;

model L02BB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.44,
    Cl             = 0.018333333333333333,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.1,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L02BB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Flutamide is a nonsteroidal antiandrogen formerly used in the treatment of prostate cancer and sometimes used off-label for other androgen-dependent conditions. It acts by inhibiting the action of androgens at the androgen receptor. Flutamide has largely been replaced by newer agents due to hepatotoxicity concerns and is not a first-line therapy today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult male volunteers under fasting conditions.</p><h4>References</h4><ol><li><p>Zuo, Z, et al., &amp; Wiebe, LI (2002). Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat. <i>Journal of pharmacy &amp; pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</i> 5(3) 292–298. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12553899/\">https://pubmed.ncbi.nlm.nih.gov/12553899</a></p></li><li><p>Mendoza, FJ, et al., &amp; Perez-Ecija, A (2017). Pharmacokinetics of the anti-androgenic drug flutamide in healthy stallions. <i>Veterinary journal (London, England : 1997)</i> 224 50–54. DOI:<a href=\"https://doi.org/10.1016/j.tvjl.2017.06.001\">10.1016/j.tvjl.2017.06.001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28697876/\">https://pubmed.ncbi.nlm.nih.gov/28697876</a></p></li><li><p>Schulz, M, et al., &amp; Becker, H (1988). The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment. <i>European journal of clinical pharmacology</i> 34(6) 633–636. DOI:<a href=\"https://doi.org/10.1007/BF00615229\">10.1007/BF00615229</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3169114/\">https://pubmed.ncbi.nlm.nih.gov/3169114</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L02BB01;
